Literature DB >> 15632181

Linking of N-Myc to death receptor machinery in neuroblastoma cells.

Hongjuan Cui1, Tai Li, Han-Fei Ding.   

Abstract

The oncogene MYCN is amplified in aggressive neuroblastomas in which caspase-8, an essential component of death receptor pathways, is frequently inactivated, suggesting a critical role of death receptor-mediated apoptosis in suppression of N-Myc oncogenic activity. Elevated levels of N-Myc sensitize neuroblastoma cells to apoptosis induced by various death ligands. Using tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis as a model, we define the mechanism underlying the sensitization effect. In neuroblastoma cells with increased expression of N-Myc, TRAIL triggers high levels of caspase-8 activation and Bid cleavage, leading to release of cytochrome c and Smac/DIABLO from mitochondria. However, the apoptotic process requires Smac/DIABLO, but not cytochrome c-mediated caspase-9 activation. N-Myc sensitizes neuroblastoma cells to TRAIL by up-regulating TRAIL receptor-2/DR5/KILLER and Bid. Moreover, DR5 mRNA is increased after N-Myc overexpression, and the human DR5 promoter contains two noncanonical E-boxes critical for the transcriptional activation by N-Myc. These findings establish a mechanistic link between N-Myc and death receptor machinery, which may serve as a checkpoint to guard the cell from N-Myc-initiated tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632181     DOI: 10.1074/jbc.M410450200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.

Authors:  Yvan H Chanthery; W Clay Gustafson; Melissa Itsara; Anders Persson; Christopher S Hackett; Matt Grimmer; Elise Charron; Slava Yakovenko; Grace Kim; Katherine K Matthay; William A Weiss
Journal:  Sci Transl Med       Date:  2012-01-04       Impact factor: 17.956

2.  A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.

Authors:  Sabine Rottmann; Yan Wang; Marc Nasoff; Quinn L Deveraux; Kim C Quon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-06       Impact factor: 11.205

3.  p53 is a direct transcriptional target of MYCN in neuroblastoma.

Authors:  Lindi Chen; Nunzio Iraci; Samuele Gherardi; Laura D Gamble; Katrina M Wood; Giovanni Perini; John Lunec; Deborah A Tweddle
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

Review 4.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  Bmi-1 is essential for the tumorigenicity of neuroblastoma cells.

Authors:  Hongjuan Cui; Bo Hu; Tai Li; Jun Ma; Goleeta Alam; William T Gunning; Han-Fei Ding
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

6.  Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma.

Authors:  Thilo S Lange; Rakesh K Singh; Kyu Kwang Kim; Yongping Zou; Satyan S Kalkunte; Giselle L Sholler; Narasimha Swamy; Laurent Brard
Journal:  Chem Biol Drug Des       Date:  2007-10       Impact factor: 2.817

7.  Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression.

Authors:  L Mao; J Ding; A Perdue; L Yang; Y Zha; M Ren; S Huang; H Cui; H-F Ding
Journal:  Oncogene       Date:  2011-11-28       Impact factor: 9.867

8.  Upstream ORF affects MYCN translation depending on exon 1b alternative splicing.

Authors:  Roger Besançon; Sandrine Valsesia-Wittmann; Clara Locher; Céline Delloye-Bourgeois; Lydie Furhman; Giovani Tutrone; Christophe Bertrand; Anne-Catherine Jallas; Elisabeth Garin; Alain Puisieux
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

9.  p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.

Authors:  Lindi Chen; Deborah A Tweddle
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

10.  Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells.

Authors:  S Mahajan; V Dammai; T Hsu; A S Kraft
Journal:  Carcinogenesis       Date:  2008-06-09       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.